Beximco Pharma Regulatory News (BXP)

BEXIMCO PHARMACEUTICALS LTD.

18TH May, 2012

AGM Notification

Notice is hereby given that the 36th annual general meeting of the Shareholders of Beximco Pharmaceuticals Limited will be held on Saturday, the 30th June, 2012 at 10.30 a.m. at Beximco Industrial Park, Sarabo, Kashimpur, Gazipur to transact the following business:

AGENDA

1. To receive, consider and adopt the Audited Financial Statements of the Company for the year ended 31st December, 2011 together with reports of the Auditors and the Directors thereon.

2. To elect Directors.

3. To declare 21% Stock Dividend.

4. To appoint Auditors for the year 2012 and to fix their remuneration.

5. To transact any other business of the Company with the permission of the Chair.

By order of the Board,

MD. ASAD ULLAH, FCS

Executive Director & Company Secretary

NOTES:

(1) The Shareholders whose names will appear in the Share Register of the Company or in the Depository Register on the record date i.e. 21 May, 2012, will be entitled to attend at the Annual General Meeting and to receive the dividend.

(2) A member entitled to attend and vote at the General Meeting may appoint a Proxy to attend and vote in his/her stead. The Proxy Form, duly stamped, must be deposited at the Registered office of the Company not later than 48 hours before the time fixed for the meeting.

(3) Admission to the meeting room will be strictly on production of the attendance slip sent with the Notice as well as verification of signature of Member(s) and/or Proxy-holder(s).

(4) No gift or benefit in cash or kind shall be paid to the holders of equity securities in terms of Clause (c) of the Notification No.SEC/SRMI/2000-953/1950 dated 24 October 2000 for attending the AGM of the Company.

For further information please visit www.beximcopharma.com or enquire at:

Beximco Pharma

Nazmul Hassan MP, Managing Director

Tel: +880 2 861 9151, ext.2080

Md. Asad Ullah, FCS, Company Secretary

Tel: +880 2 8618220-1, Ext 1140

Libertas Capital Corporate Finance

Thilo Hoffmann

Tel: +44 (0)20 7569 9650

FTI Consulting

Jonathan Birt / Susan Quigley/ Simon Conway

Tel: +44 (0)20 7269 7169

Notes to Editors

About Beximco Pharmaceuticals Limited

Founded in 1976 and based in Dhaka, Bangladesh, BPL manufactures and sells generic pharmaceutical formulation products and active pharmaceutical ingredients. The Company manufactures and markets its own branded generics for almost all diseases. The Company also undertakes contract manufacturing for multinational pharmaceutical companies. The Company operates from a 20 acre site in Dhaka and currently employs over 2500 staff.

The Company's products are sold to retail outlets, medical institutions and other pharmaceutical manufacturers in Bangladesh, in regional markets such as Sri Lanka, Nepal, Bhutan, Vietnam, Cambodia and Myanmar and in other markets overseas, principally in East Africa, Pacific Island and Central American countries and South East Asia, including Singapore and Hong Kong.